FDA Approves Dupixent for Some Patients Struggling With COPD Symptoms
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for certain adults with poorly controlled chronic obstructive pulmonary disease (COPD) . The FDA…